UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Grading and staging systems for inflammation and fibrosis in chronic liver diseases

Journal of hepatology, 2007-10, Vol.47 (4), p.598-607

Goodman, Zachary D

2007

Link zum Volltext

Verfügbarkeit prüfen

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1207-1217

2011

Link zum Volltext

Verfügbarkeit prüfen

Liver biopsy

Hepatology (Baltimore, Md.), 2009-03, Vol.49 (3), p.1017-1044

2009

Link zum Volltext

Verfügbarkeit prüfen

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality

Hepatology (Baltimore, Md.), 2011-06, Vol.53 (6), p.1874-1882

2011

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen–positive patients

Hepatology (Baltimore, Md.), 2010-11, Vol.52 (5), p.1611-1620

2010

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

The New England journal of medicine, 2006-03, Vol.354 (10), p.1001-1010

2006

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long‐term treatment against cirrhosis trial

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.585-594

2010

Link zum Volltext

Verfügbarkeit prüfen

Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis

Hepatology (Baltimore, Md.), 2007-04, Vol.45 (4), p.886-894

2007

Link zum Volltext

Verfügbarkeit prüfen

Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds‐C Trial

Hepatology (Baltimore, Md.), 2008-03, Vol.47 (3), p.836-843

2008

Link zum Volltext

Verfügbarkeit prüfen

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

The New England journal of medicine, 2003-02, Vol.348 (9), p.800-807

2003

Link zum Volltext

Verfügbarkeit prüfen

Malignant Hepatic Angiomyolipoma : Report of a Case and Review of Literature

The American journal of surgical pathology, 2008-05, Vol.32 (5), p.793-798

2008

Link zum Volltext

Verfügbarkeit prüfen

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

The New England journal of medicine, 2003-02, Vol.348 (9), p.808-816

2003

Link zum Volltext

Verfügbarkeit prüfen

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C

Gut, 2010-10, Vol.59 (10), p.1401-1409

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C

Hepatology (Baltimore, Md.), 2001-08, Vol.34 (2), p.395-403

2001

Link zum Volltext

Verfügbarkeit prüfen

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

Hepatology (Baltimore, Md.), 2008-03, Vol.47 (3), p.789-798

2008

Link zum Volltext

Verfügbarkeit prüfen

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests : Results of the HALT-C cohort

Hepatology (Baltimore, Md.), 2005-08, Vol.42 (2), p.282-292

2005

Link zum Volltext

Verfügbarkeit prüfen

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

The New England journal of medicine, 1998-11, Vol.339 (21), p.1485-1492

1998

Link zum Volltext

Verfügbarkeit prüfen

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT‐C trial

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1738-1749

2009

Link zum Volltext

Verfügbarkeit prüfen

Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma

Human pathology, 2008-02, Vol.39 (2), p.209-212

2008

Link zum Volltext

Verfügbarkeit prüfen

An Immunohistochemical Profile of the So-called Bile Duct Adenoma: Clues to Pathogenesis

The American journal of surgical pathology, 2010-09, Vol.34 (9), p.1312-1318

2010

Link zum Volltext

Verfügbarkeit prüfen

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2005-09, Vol.42 (3), p.665-674

2005

Link zum Volltext

Verfügbarkeit prüfen

Calcifying Nested Stromal-epithelial Tumors of the Liver: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 9 Cases With a Long-term Follow-up

The American journal of surgical pathology, 2009-07, Vol.33 (7), p.976-983

2009

Link zum Volltext

Verfügbarkeit prüfen

Final results of a double‐blind, placebo‐controlled trial of the antifibrotic efficacy of interferon‐γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

Hepatology (Baltimore, Md.), 2007-03, Vol.45 (3), p.569-578

2007

Link zum Volltext

Verfügbarkeit prüfen

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

The New England journal of medicine, 1999-10, Vol.341 (17), p.1256-1263

1999

Link zum Volltext

Verfügbarkeit prüfen

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B

Journal of hepatology, 2001-12, Vol.35 (6), p.749-755

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(106)

Sprache

Englisch
(106)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(106)
Humans
(98)
Life Sciences & Biomedicine
(96)
Science & Technology
(96)
Female
(81)
Male
(75)
Adult
(71)
Middle Aged
(69)
Gastroenterology & Hepatology
(49)
Infectious Diseases
(47)
Human Viral Diseases
(45)
Viral Diseases
(45)
Gastroenterology. Liver. Pancreas. Abdomen
(44)
Viral Hepatitis
(42)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(40)
Aged
(37)
Liver - Pathology
(33)
Pharmacology. Drug Treatments
(26)
Antiviral Agents - Therapeutic Use
(24)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Grading and staging systems for inflammation and fibrosis in chronic liver diseases

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Liver biopsy

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen–positive patients

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long‐term treatment against cirrhosis trial

Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis

Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds‐C Trial

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

Malignant Hepatic Angiomyolipoma : Report of a Case and Review of Literature

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests : Results of the HALT-C cohort

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT‐C trial

Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma

An Immunohistochemical Profile of the So-called Bile Duct Adenoma: Clues to Pathogenesis

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease

Calcifying Nested Stromal-epithelial Tumors of the Liver: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 9 Cases With a Long-term Follow-up

Final results of a double‐blind, placebo‐controlled trial of the antifibrotic efficacy of interferon‐γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B

Aktive Filter

Suchergebnisse filtern